Boston Partners Long/Short Research Fund EBIT

The latest EBIT for BPIRX is $420M as of December 2023. That is below the sector sector average of $2.6T. Investors often review this figure alongside Boston Partners Long/Short Research Fund's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, BPIRX currently prints $420M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Boston Partners Long/Short Research Fund's growth, margins, and balance sheet.

A EBIT figure of $420M for BPIRX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting BPIRX's EBIT ($420M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.